Your email has been successfully added to our mailing list.

×
0.000620925178516086 -0.000310462589257933 -0.000620925178515865 -0.00155231294628988 -0.000620925178515865 -0.000620925178515865 -0.000620925178515865 -0.000620925178515865
Stock impact report

SEC fines Clovis Oncology Inc., executives $20.8 million for lying about cancer drug effectiveness [MarketWatch]

Clovis Oncology, Inc. (CLVS) 
Last clovis oncology, inc. earnings: 2/24 04:05 pm Check Earnings Report
Company Research Source: MarketWatch
SEC fines Clovis Oncology Inc., executives $20.8 million for lying about cancer drug effectiveness Clovis Oncology Inc., CLVS, +0.03% will pay $20 million to settle charges by the Securities and Exchange Commission that it misled investors about the effectiveness of the company's developmental lung cancer drug, rociletinib, or Roci, according to an SEC press release. Its CEO Patrick Mahaffy, and Erle Mast, the company's former CFO, also settled charges. Over a four-month period starting in July 2015, the company and Mahaffy used its investor presentations, press releases, and SEC filings to inaccurately state that the drug was effective 60% of the time, meaning that in 60% of patients Roci caused targeted tumors to shrink, despite knowing actual results were much lower. Clovis raised approximately $298 million in a public stock offering in July 2015, but its stock price dropped by 70% in November 2015 after disclosing the true effectiveness rate, 28%. The company stopped developmen Show less Read more
Impact Snapshot
Event Time:
CLVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CLVS alerts
Opt-in for
CLVS alerts

from News Quantified
Opt-in for
CLVS alerts

from News Quantified